Afyren SAS

https://www.afyren.com

To meet manufacturers' growing need to combat global warming and reduce the use of petroleum derivatives in their production chain, AFYREN produces biomolecules derived from the recycling of non-food biomass, widely used in human and animal nutrition, flavours and fragrances, life sciences, materials sciences and lubricants sectors. This production of renewable carbon, which is resolutely part of a circular economy, is carried out using fermentative technologies patented worldwide, the result of 10 years of research. Founded in 2012 and managed by Nicolas Sordet and Jérémy Pessiot, AFYREN employs 33 people (as of year-end 2020) at its sites in Lyon, Clermont-Ferrand and Carling - Saint Avold. AFYREN is the winner of the 2030 Global Innovation Contest in the "Plant proteins and plant chemistry" category and was selected in the French Tech120 in January 2020 and 2021. In 2018, AFYREN embarked on the implementation of its industrial project with the creation of a joint venture with Bpifrance's SPI fund: AFYREN NEOXY. AFYREN NEOXY is dedicated to the first industrial production of AFYREN natural organic acids in the Grand Est region. *

	Start	2012-01-01 established
	Group	Afyren (Group)
	Industry	industrial biotechnology
	Industry 2	GREEN BIOTECHNOLOGY
	Person	Sordet, Nicolas (Afyren 202108 CEO + Co-Founder before Link Securities + BNP Paribas + Société Générale)
	Person 2	Pessiot, Jérémy (Afyren 202108 Managing Director + CTO + Co-Founder)

	Street	9-11 rue Gutenberg
	City	63100 Clemont-Ferrand
	Tel	+33-4-7390-5116
		Address record changed: 2021-09-01

Basic data	Employees	B: 11 to 50 (2020-12-31)
	Annual sales	3,991,000 (revenues, consolidated (2020) 2020-12-31)
	Profit	-2,133,000 (2020-12-31)
	Cash	9,508,000 (2020-12-31)

		* Document for »About Section«: Afyren SAS. (8/26/21). "Press Release: Afyren, the Innovative Greentech for Sustainable Chemistry, Announces Its Planned IPO on Euronext Growth® in Paris [Not for US, CA, et al.]". Clermont-Ferrand.

		Record changed: 2024-03-30

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Afyren (Group)

[1] Afyren SAS. (8/26/21). "Press Release: Afyren, the Innovative Greentech for Sustainable Chemistry, Announces Its Planned IPO on Euronext Growth® in Paris [Not for US, CA, et al.]". Clermont-Ferrand....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)